Skip to content

Life Sciences

Site change control and the registered details

  • Life Sciences
  • 1 min read

A new mixer went in under site change control. Open the registered process description and it describes the old one.

Nobody skipped a step. Engineering assessed the installation, QA assessed the GMP impact, and the form had no line asking what the marketing authorisation says about this piece of equipment. The gap surfaces months later, when someone lays the registered process description beside a batch record.

ICH Q10 is direct about it. Proposed changes should be evaluated relative to the marketing authorisation, and there should be an assessment to determine whether a change to the regulatory filing is required under regional requirements. It names Regulatory Affairs among the areas whose expertise should evaluate a proposed change. EU GMP Annex 15 (2015) lists regulatory status among the things a planned change should be evaluated against.

In practice that is a few small additions to the change control procedure. The form asks, for every change, whether the dossier describes the item being changed. Regulatory affairs is an assessor on the form and is asked at the proposal stage. Where a filing is needed, its category is settled before the change is implemented, because ICH Q12 separates changes that require prior approval from those that are notified.

Engineering's part is to ask the question while the purchase order is still a draft.

Topics

Industries

Related

More on this subject

Taking over a facility: start with a written gap assessment

Before changing an inherited facility or design, a written gap assessment against the URS and target regulations gives management and inspectors the same picture: evidence from documents and spot measurements, findings graded by risk, and the fix, cost range and schedule impact of each, plus what can stay.

InsightRead

The four phases of a technology transfer

WHO Technical Report Series 1044, Annex 4, says a technology transfer project may be divided into four phases: initiation, planning, transfer execution, and review and close-out. A project that begins with the first trial batch has skipped the gap analysis, the transfer protocol and the knowledge package, and cannot explain a failed batch.

InsightRead

The receiving site validates the process again

A process validated at the sending site was validated with that site's equipment, utilities and people. WHO's technology transfer guideline defines validation batches as those produced by the receiving unit, and EU GMP Annex 15 (2015) covers site transfers. The earlier validation supports the new protocol. With bracketing, the number of batches could be reduced; the content of the previous validation should be available.

InsightRead